1. Home
  2. PBM vs GSIW Comparison

PBM vs GSIW Comparison

Compare PBM & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • GSIW
  • Stock Information
  • Founded
  • PBM 1994
  • GSIW 2016
  • Country
  • PBM Canada
  • GSIW Hong Kong
  • Employees
  • PBM N/A
  • GSIW N/A
  • Industry
  • PBM
  • GSIW
  • Sector
  • PBM
  • GSIW
  • Exchange
  • PBM NYSE
  • GSIW Nasdaq
  • Market Cap
  • PBM 5.3M
  • GSIW 12.3M
  • IPO Year
  • PBM N/A
  • GSIW 2023
  • Fundamental
  • Price
  • PBM $1.38
  • GSIW $0.51
  • Analyst Decision
  • PBM
  • GSIW
  • Analyst Count
  • PBM 0
  • GSIW 0
  • Target Price
  • PBM N/A
  • GSIW N/A
  • AVG Volume (30 Days)
  • PBM 386.4K
  • GSIW 11.8M
  • Earning Date
  • PBM 02-02-2025
  • GSIW 12-31-2024
  • Dividend Yield
  • PBM N/A
  • GSIW N/A
  • EPS Growth
  • PBM N/A
  • GSIW N/A
  • EPS
  • PBM N/A
  • GSIW N/A
  • Revenue
  • PBM N/A
  • GSIW $1,313,795.00
  • Revenue This Year
  • PBM N/A
  • GSIW N/A
  • Revenue Next Year
  • PBM N/A
  • GSIW N/A
  • P/E Ratio
  • PBM N/A
  • GSIW N/A
  • Revenue Growth
  • PBM N/A
  • GSIW N/A
  • 52 Week Low
  • PBM $1.15
  • GSIW $0.43
  • 52 Week High
  • PBM $323.25
  • GSIW $15.00
  • Technical
  • Relative Strength Index (RSI)
  • PBM 36.81
  • GSIW 44.50
  • Support Level
  • PBM $1.15
  • GSIW $0.46
  • Resistance Level
  • PBM $1.59
  • GSIW $0.57
  • Average True Range (ATR)
  • PBM 0.19
  • GSIW 0.11
  • MACD
  • PBM 0.02
  • GSIW -0.00
  • Stochastic Oscillator
  • PBM 14.60
  • GSIW 5.64

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

Share on Social Networks: